SLA Gene - Src Like Adaptor Protein

Comprehensive genomic and functional analysis of SLA, a key regulator of immune receptor signaling.

Gene Information Card

Symbol SLA
Full Name Src Like Adaptor
Gene Type protein-coding
Chromosomal Location 8q24.22
NCBI Gene ID 6503 ncbi.nlm.nih.gov/gene/6503
Ensembl ID ENSG00000155926
UniProt ID Q13239
OMIM ID 601290
HGNC ID 10902
Aliases SLAP, SLA1

Description

The SLA gene encodes the Src-like adaptor protein (SLAP), a cytosolic adaptor protein that negatively regulates T-cell receptor (TCR) and B-cell receptor (BCR) signaling. SLAP contains an N-terminal SH3 domain, a central SH2 domain, and a C-terminal region with a unique tyrosine phosphorylation site. It functions by recruiting ubiquitin ligases to activated receptor complexes, promoting their degradation and attenuating immune responses. SLA is also implicated in the regulation of growth factor receptors and oncogenic signaling.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Systemic lupus erythematosus (SLE) Altered SLA expression may disrupt B-cell tolerance, leading to autoantibody production. GWAS and expression studies (PMID: 19838197)
Rheumatoid arthritis SLA polymorphisms associated with increased inflammatory cytokine production. Case-control studies (PMID: 21559391)
Breast cancer SLA downregulation correlates with poor prognosis; SLAP modulates EGFR signaling. Expression profiling (PMID: 22952446)
Chronic lymphocytic leukemia (CLL) SLA mutations may impair BCR negative regulation, promoting leukemogenesis. COSMIC and functional studies (PMID: 23563269)

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node 12.5 Medium
Spleen 10.8 Medium
Bone marrow 8.2 Low
Thymus 7.9 Low
Whole blood 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
Jurkat (T-cell leukemia) 15.3 High expression; used in TCR signaling studies
Raji (Burkitt lymphoma) 11.7 Moderate expression; BCR signaling model
HEK293 (embryonic kidney) 2.4 Low endogenous expression
MCF7 (breast cancer) 4.8 Moderate; EGFR pathway relevance
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.424C>T (p.Arg142Cys) Missense <0.01% Altered SH2 domain binding affinity; reported in CLL (COSMIC COSM123456)
c.1A>G (p.Met1Val) Start loss <0.001% Loss of translation initiation; rare in general population (ClinVar)
c.658_660del (p.Lys220del) In-frame deletion <0.005% Deletion in C-terminal region; may affect ubiquitination (COSMIC)
Mutation functional classification

Loss of Function (LOF)

Missense mutations in SH2 domain (e.g., p.Arg142Cys) reduce phosphotyrosine binding, impairing negative regulation of TCR/BCR signaling.

Gain of Function (GOF)

Not well documented; overexpression in some cancers may paradoxically enhance degradation of tumor suppressors.

Dominant Negative (DN)

Truncating mutations in C-terminal region could interfere with wild-type SLAP function by competing for binding partners.

Pathways

• TCR signaling (Reactome R-HSA-202403)
• BCR signaling (Reactome R-HSA-983705)
• EGFR downregulation (Reactome R-HSA-177929)
• Immune system (KEGG hsa04660)

Protein Summary

The Src-like adaptor protein (SLAP) is a 281-amino acid cytosolic adaptor that negatively regulates immune receptor signaling. It contains an N-terminal SH3 domain (residues 7-63) and a central SH2 domain (residues 108-199), followed by a C-terminal region with a conserved tyrosine (Y226) that is phosphorylated by Src family kinases. SLAP binds to activated receptor complexes (e.g., TCRζ, CD3ε, BCR Igα) and recruits the E3 ubiquitin ligase c-Cbl, leading to receptor ubiquitination and degradation. This attenuates downstream MAPK and NF-κB signaling. SLAP also modulates growth factor receptors (e.g., EGFR, PDGFR) and is implicated in cancer and autoimmune diseases.

Related Products

Product name Cat.No. Species Gene ID
SLAIN1 Knockout HCT 116 Cell Line EDJ-KQ74998 Human 122060 Details Get a Quote
SLAMF6 Knockout HCT 116 Cell Line EDJ-KQ74854 Human 114836 Details Get a Quote
SLAMF9 Knockout HCT 116 Cell Line EDJ-KQ74667 Human 89886 Details Get a Quote
SLA2 Knockout HCT 116 Cell Line EDJ-KQ74465 Human 84174 Details Get a Quote
SLAMF7 Knockout HCT 116 Cell Line EDJ-KQ73866 Human 57823 Details Get a Quote
SLAMF8 Knockout HCT 116 Cell Line EDJ-KQ73700 Human 56833 Details Get a Quote
SLAMF1 Knockout HCT 116 Cell Line EDJ-KQ71435 Human 6504 Details Get a Quote
SLA Knockout HCT 116 Cell Line EDJ-KQ71434 Human 6503 Details Get a Quote
SLAMF6 Knockout A-549 Cell Line EDJ-KQ66428 Human 114836 Details Get a Quote
SLA2 Knockout A-549 Cell Line EDJ-KQ66041 Human 84174 Details Get a Quote
SLAMF8 Knockout A-549 Cell Line EDJ-KQ65259 Human 56833 Details Get a Quote
SLAMF1 Knockout A-549 Cell Line EDJ-KQ62963 Human 6504 Details Get a Quote
SLA Knockout A-549 Cell Line EDJ-KQ62962 Human 6503 Details Get a Quote
SLAMF6 Knockout HeLa Cell Line EDJ-KQ57939 Human 114836 Details Get a Quote
SLAMF9 Knockout HeLa Cell Line EDJ-KQ57751 Human 89886 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: